Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

Todd Neale

July 17, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

Todd Neale

April 10, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests

Michael O'Riordan

January 23, 2019

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Daily News

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

Ashley Lyles

August 15, 2017

News Industry News

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

January 03, 2016

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Daily News

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

March 09, 2013

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

Advertisement

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

March 2023 News Roundup

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content